InvestorsHub Logo
Followers 7
Posts 98
Boards Moderated 0
Alias Born 06/09/2020

Re: None

Friday, 04/23/2021 2:45:06 PM

Friday, April 23, 2021 2:45:06 PM

Post# of 345950
Figured I'd help everyone enjoy the weekend. Avid has a new commercial customer.

Moments ago, ADC Therapeutics announced FDA approval of Zynlonta, previously known under the name Lonca. The approval deadline was May 21st, so this was approved early.

Avid is the manufacturer of the antibody. See slide 25:

https://s24.q4cdn.com/575174480/files/doc_presentations/2021/04/ADCT-Corporate-Presentation-April-2021-v3-(optimized).pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News